Optiflow™
nasal high flow therapy

Proven* respiratory support

*A review of studies comprising the body of NHF evidence found the majority used F&P Optiflow™ systems

Frequently Asked Questions

Latest Flow Matters Publication

Optiflow NHF in practice

Contact Us - Email/Phone


High flow nasal cannula (HFNC), high flow therapy (HFT), high flow oxygen/therapy (HFO/T), nasal high flow (NHF), high flow nasal prongs (HFNP), high flow oxygen (HFO), humidified high flow nasal cannula (HHFNC), heated, humidified high flow nasal cannula (HHHFNC), humidified high flow therapy (HHFT), nasal insufflation or just plain high flow (HF).

While many terms are used for this therapy, one name stands out as the way to deliver it: Optiflow NHF therapy

Optiflow NHF therapy from Fisher & Paykel Healthcare is at the forefront of its field, featuring in hundreds of publications and prestigious journals such as NEJM and JAMA.

Using Optiflow NHF therapy as a first-line treatment (both pre-intubation and post-extubation) may reduce a patient's escalation "up the acuity curve", resulting in better patient outcomes.

 

Clinical Practice Guidelines for Nasal High Flow Therapy


“This clinical practice guideline synthesizes current best evidence into four recommendations for NHF in adult patients.”1


Nasal High Flow (NHF) therapy is recommended for use in several applications by published guidelines. A clinical practice guideline for NHF use as a respiratory strategy in adult patients requiring respiratory support was recently published in Intensive Care Medicine,1 the official journal of The European Society of Intensive Care Medicine (ESICM).

1. Rochwerg et al. 2020. Intensive Care Med.

 

Acute hypoxemic
respiratory failure

For primary respiratory support compared to COT.
Recommendation made with moderate certainty.


 

 Strong
Recommendation 

Post-operative
 
For primary respiratory support compared to COT in high risk and/or obese patients following cardiac or thoracic surgery.
Recommendation made with moderate certainty.


 Conditional Recommendation 
Peri-intubation
 
For pre-oxygenation prior to in-ICU intubation no recommendation is made compared to COT.
NHF during intubation should be continued for patients who are already receiving NHF.*

 Continue NHF* 
Post-extubation
respiratory failure
 
For post-extubation respiratory support compared to COT following extubation.
Recommendation made with moderate certainty.



 Conditional Recommendation 

*For patients who are already receiving NHF, guideline authors suggest continuing NHF during intubation (conditional recommendation, moderate certainty).

High flow in adults - Dr.Laurent Brochard


Watch Dr. Laurent Brochard present the ESICM clinical practice guidelines for use of NHF therapy as a respiratory support for adult patients. (28 mins)

 


Download this visual abstract for an overview of the clinical practice guideline.




 


Read our Flow Matters publication dedicated to the clinical practice guideline.




 



 
Discuss Optiflow High Flow Therapy with us



Optiflow Nasal High Flow in Practice

Optiflow™ Nasal High Flow at the Royal Berkshire Hospital (Optiflow Page)

A multi-department implementation of Optiflow NHF therapy

This video shows the introduction of the Airvo 2 device across departments of the Royal Berkshire Hospital in Reading, UK. Hospital clinicians talk about the benefits for the hospital and its patient since the Airvo 2 was introduced.
Extubating to Optiflow™ Nasal High Flow therapy

Extubation to Optiflow NHF therapy: Dr Hernández

This video depicts extubation to Optiflow NHF therapy, and is based on the procedure used by Dr. Hernández and his colleagues in the following studies: Hernández et al. JAMA. 2016 (April)1 and Hernández et al. JAMA 2016 (Oct.)2

ROX Index Explained

The ROX index can be used to monitor patients and predict the likelihood of NHF therapy success or failure. 

It combines three common measurements: FiO2, SpO2, and respiratory rate, and it is based on two known facts about sicker patients. 1. They require more oxygen. 2. They have a higher respiratory rate.

The index has been validated in a multi-center prospective study conducted with 191 patients with pneumonia.*

Read Online  Download PDF



 




ROX* Index
Calculator
app
 
Use the ROX Index
Calculator app
to learn about
entering the
parameters
and calculating the
index.



 
 




ROX* Vector
app
 
Use the ROX
Vector app to learn
about visualizing trends
in the parameters
over time.




 
Search our FAQs

Enter keyword


 

Options for Delivering Optiflow NHF Therapy

Airvo 2 - a dedicated Optiflow NHF system
MR850 heated humidifier (blender required)
Learn about your options for delivering Optiflow NHF therapy
Learn more about interfaces/cannula

Support Resources

Webpages

Optiflow NHF therapy FAQs


LinkedIn  Twitter

Latest Flow Matters publication


LinkedIn  Twitter

Apps/PDFs/Videos


ROX Index* Calculator app

Free and available from the app Store and Google Play


ROX Vector* app

Free and available from the app Store and Google Play


Optiflow NHF therapy brochure



 

LinkedIn  Twitter


Call us

1800 446 3908 / +1949 453 4000



or get in touch by email

 


 

Optiflow Nasal High Flow

 
ENQUIRY FORM
 
 

If you have an enquiry about our products, please provide the following information so a Fisher & Paykel Healthcare representative can contact you. For further details on how this information will be used, see below or go to our privacy statement.

   



   

 		  


   


Select your country of residence
   

   
 
   
Enter security code
 Security code
   
By submitting this form, you consent to Fisher & Paykel Healthcare storing your personal information to contact you about your enquiry. Your information will be collected and stored securely by Fisher & Paykel Healthcare Limited based in New Zealand and may be shared with the wider Fisher & Paykel Healthcare group as necessary to support your enquiry. We will not share, disclose or sell your information to third parties for marketing purposes. For full details on how we use and manage your personal information, how long we may retain this information for sales or marketing purposes, your rights to access, correct or delete your personal information, and how to contact us about your personal information, please see our privacy statement.
   
 
 

 

The outbreak of COVID-19 has impacted healthcare organizations around the world

A resource center has been created to provide affected hospitals and healthcare professionals with information they may need to treat patients when using Fisher & Paykel Healthcare products.
 

View resource center